SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Rydén E) "

Sökning: WFRF:(Rydén E)

  • Resultat 11-20 av 250
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  •  
17.
  • Dollet, L, et al. (författare)
  • Glutamine Regulates Skeletal Muscle Immunometabolism in Type 2 Diabetes
  • 2022
  • Ingår i: Diabetes. - : American Diabetes Association. - 1939-327X .- 0012-1797. ; 71:4, s. 624-636
  • Tidskriftsartikel (refereegranskat)abstract
    • Dysregulation of skeletal muscle metabolism influences whole-body insulin sensitivity and glucose homeostasis. We hypothesized that type 2 diabetes–associated alterations in the plasma metabolome directly contribute to skeletal muscle immunometabolism and the subsequent development of insulin resistance. To this end, we analyzed the plasma and skeletal muscle metabolite profile and identified glutamine as a key amino acid that correlates inversely with BMI and insulin resistance index (HOMA-IR) in men with normal glucose tolerance or type 2 diabetes. Using an in vitro model of human myotubes and an in vivo model of diet-induced obesity and insulin resistance in male mice, we provide evidence that glutamine levels directly influence the inflammatory response of skeletal muscle and regulate the expression of the adaptor protein GRB10, an inhibitor of insulin signaling. Moreover, we demonstrate that a systemic increase in glutamine levels in a mouse model of obesity improves insulin sensitivity and restores glucose homeostasis. We conclude that glutamine supplementation may represent a potential therapeutic strategy to prevent or delay the onset of insulin resistance in obesity by reducing inflammatory markers and promoting skeletal muscle insulin sensitivity.
  •  
18.
  •  
19.
  • Heggebo, L. C., et al. (författare)
  • Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
  • 2023
  • Ingår i: Bmj Open. - : BMJ. - 2044-6055. ; 13:3
  • Tidskriftsartikel (refereegranskat)abstract
    • IntroductionThe use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from radiation. This is principally beneficial and holds promise of reduced long-term side effects. However, the sparing of seemingly non-cancerous tissue is not necessarily positive for isocitrate dehydrogenase (IDH)-mutated diffuse gliomas grade 2-3, which have a diffuse growth pattern. With their relatively good prognosis, yet incurable nature, therapy needs to be delicately balanced to achieve a maximal survival benefit combined with an optimised quality of life.Methods and analysisPRO-GLIO (PROton versus photon therapy in IDH-mutated diffuse grade 2 and 3 GLIOmas) is an open-label, multicentre, randomised phase III non-inferiority study. 224 patients aged 18-65 years with IDH-mutated diffuse gliomas grade 2-3 from Norway and Sweden will be randomised 1:1 to radiotherapy delivered with protons (experimental arm) or photons (standard arm). First intervention-free survival at 2 years is the primary endpoint. Key secondary endpoints are fatigue and cognitive impairment, both at 2 years. Additional secondary outcomes include several survival measures, health-related quality of life parameters and health economy endpoints.Ethics and disseminationTo implement proton therapy as part of standard of care for patients with IDH-mutated diffuse gliomas grade 2-3, it should be deemed safe. With its randomised controlled design testing proton versus photon therapy, PRO-GLIO will provide important information for this patient population concerning safety, cognition, fatigue and other quality of life parameters. As proton therapy is considerably more costly than its photon counterpart, cost-effectiveness will also be evaluated. PRO-GLIO is approved by ethical committees in Norway (Regional Committee for Medical & Health Research Ethics) and Sweden (The Swedish Ethical Review Authority) and patient inclusion has commenced. Trial results will be published in international peer-reviewed journals, relevant conferences, national and international meetings and expert forums.Trial registration numberClinicalTrials.gov Registry (NCT05190172).
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 250
Typ av publikation
tidskriftsartikel (212)
konferensbidrag (28)
forskningsöversikt (4)
konstnärligt arbete (3)
bokkapitel (2)
annan publikation (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (195)
övrigt vetenskapligt/konstnärligt (55)
Författare/redaktör
Rydén, L. (102)
Ryden, M (76)
Arner, P (52)
Standl, E (29)
Naslund, E (25)
Reiner, Z (18)
visa fler...
Norhammar, A. (18)
Ceriello, A. (16)
De Backer, G (16)
Wood, D. (16)
Schnell, O (16)
Pogosova, N (15)
Thorell, A (14)
Dahlman, I (14)
Mejhert, N (14)
Cosentino, F (12)
Arner, E (12)
Malmberg, K (11)
Laurencikiene, J (11)
Perk, J. (11)
Dicker, A (11)
Langin, D (11)
Marx, N (11)
Cifkova, R (11)
Rydén, Lisa (10)
Ryden, S (10)
Andersson, DP (10)
Zamorano, JL (10)
Gustafsson, A (10)
Mellbin, L (10)
van Harmelen, V (9)
Svenungsson, E (9)
Ferrannini, G. (9)
De Bacquer, D (9)
Dagenais, GR (9)
Graham, I (9)
Kotseva, K (9)
Diaz, R. (8)
Soderberg, M (8)
Crowley, J (8)
Hoffstedt, J (8)
Lindahl, B (8)
Lanas, F. (8)
Lopez-Jaramillo, P. (8)
Kulyte, A (8)
Sjolin, E (8)
Keltai, M (8)
Probstfield, J (8)
Rodbard, HW (8)
Hoes, A (8)
visa färre...
Lärosäte
Karolinska Institutet (198)
Göteborgs universitet (29)
Lunds universitet (28)
Kungliga Tekniska Högskolan (21)
Uppsala universitet (17)
Umeå universitet (14)
visa fler...
Linköpings universitet (10)
Stockholms universitet (4)
Örebro universitet (3)
Linnéuniversitetet (3)
Malmö universitet (2)
Luleå tekniska universitet (1)
Mälardalens universitet (1)
Gymnastik- och idrottshögskolan (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (245)
Svenska (4)
Portugisiska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (80)
Naturvetenskap (8)
Humaniora (3)
Samhällsvetenskap (2)
Teknik (1)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy